-
RBPMS promotes contractile phenotype splicing in human embryonic stem cell derived vascular smooth muscle cells Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-09 Aishwarya G Jacob, Ilias Moutsopoulous, Alex Petchey, Rafael Kollyfas, Vincent R Knight-Schrijver, Irina Mohorianu, Sanjay Sinha, Christopher W J Smith
Aims Differentiated Vascular Smooth Muscle Cells (VSMCs) express a unique network of mRNA isoforms via smooth muscle specific alternative splicing (SM-AS) in functionally critical genes, including those comprising the contractile machinery. We previously described RNA Binding Protein Multiple Splicing (RBPMS) as a potent driver of differentiated SM-AS in the rat PAC1 VSMC cell line. What is unknown
-
Liver kinase B1 - a master regulator of vascular smooth muscle cell fate and vascular metabolic homeostasis? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-09 Meredith Whitehead,Catherine M Shanahan
-
Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-07 Yoriko Heianza, Xuan Wang, Minghao Kou, Saumya Tiwari, Jeramie D Watrous, Kathryn M Rexrode, Mona Alotaibi, Mohit Jain, Qi Sun, JoAnn E Manson, Lu Qi
Aims Circulating dimethylguanidino valeric acid (DMGV) was identified as a novel metabolite related to cardiorespiratory fitness and cardiometabolic abnormalities. Circulating DMGV levels are subjective to dietary modulation; however, studies on its associations with intakes of coronary heart disease (CHD)-related foods/nutrients are limited. We investigated whether plasma DMGV was related to risk
-
SCUBE2, where are you? Recruitment of SCUBE2 to adherens junctions preserves vascular health and integrity. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-06 Wendy Stam,Coert Margadant
-
Identifying optimal reference genes for qRT-PCR in human myocardial tissues. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-06 Maria Camacho-Encina,Laura K Booth,Rachael Redgrave,Minna Honkanen-Scott,William E Scott,Carmen Martin-Ruiz,Guy MacGowan,Sarah Richardson,John Dark,Simon Tual-Chalot,Gavin D Richardson
-
Modulation of MMP9 and CXCR2/CXCL1/IL-8 axis in human abdominal aortic aneurysm tissues by ladarixin. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-05 Maria Lombardi,Lucia Spartano,Sabrina Nicolo,Vincenzo Ardita,Roberto Chiesa,Andrea Aramini,Marcello Allegretti,Domenico Baccellieri,Lidia De Filippis,Chiara Foglieni
-
Olfr2-positive macrophages originate from monocytes proliferate in situ and present a pro-inflammatory foamy-like phenotype Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-05 Sujit Silas Armstrong Suthahar, Felix Sebastian Nettersheim, Ahmad Alimadadi, Erpei Wang, Monica Billitti, Natalya Resto-Trujillo, Payel Roy, Catherine C Hedrick, Klaus Ley, Marco Orecchioni
Aims Olfactory receptor 2 (Olfr2) has been identified in a minimum of 30% of vascular macrophages, and its depletion was shown to reduce atherosclerosis progression. Mononuclear phagocytes, including monocytes and macrophages within the vessel wall, are major players in atherosclerosis. Single-cell RNA sequencing studies revealed that atherosclerotic artery walls encompass several monocytes and vascular
-
Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-02 David J Webb
-
International partnership to nurture future cardiovascular research leaders in Europe. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-31 Metin Avkiran
-
Plasma biomarkers of inflammation associate with blood pressure and arterial stiffness in adolescents after very preterm birth. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-28 Anja Meissner,Jonas Liefke,Frank Matthes,Eva Morsing,David Ley,Erik Hedström
-
Unlocking unknown mutations to understand causal relationships in cardiovascular science: paving the path to personalized cardiovascular care. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-28 Soumaya Ben-Aicha Gonzalez,Dorian Haskard
-
Early coronary revascularization among “stable” patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-28 Natalia Fabin, Edina Cenko, Maria Bergami, Jinsung Yoon, Giuseppe Vadalà, Guiomar Mendieta, Sasko Kedev, Jorgo Kostov, Marija Vavlukis, Elif Vraynko, Davor Miličić, Zorana Vasiljevic, Marija Zdravkovic, Lina Badimon, Alfredo R Galassi, Olivia Manfrini, Raffaele Bugiardini
Aims To investigate the impact of an early coronary revascularization (<24 hours) compared with initial conservative strategy on clinical outcomes in diabetic patients with non-ST elevation acute coronary syndrome (NSTE-ACS) who are in stable condition at hospital admission. Methods and Results The ISACS-TC database was queried for a sample of diabetic and nondiabetic patients with diagnosis of NSTE-ACS
-
Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-28 Qian Li, Jialin Fu, Kyoungmin Park, Hetal Shah, Qin Li, I-Hsien Wu, George L King
Aims Increased prevalence of acute myocardial infarction related to diabetes and insulin resistance is associated with elevated risk for unstable atherosclerotic plaques, which are characterized by reduced vascular smooth muscle cells (VSMC) and extracellular matrix (ECM) and increased inflammation. Thus, insulin resistance may reduce plaque stability as deleting insulin receptors (IR) in VSMC decreased
-
Regulation of Ptbp1-controlled alternative splicing of pyruvate kinase muscle by Liver kinase b1 governs vascular smooth muscle cell plasticity in vivo Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-27 Zhaohua Cai, Ganesh Satyanarayana, Ping Song, Fujie Zhao, Shaojin You, Zhixue Liu, Jing Mu, Ye Ding, Ben He, Ming-Hui Zou
Aims Vascular smooth muscle cell (VSMC) plasticity is a state in which VSMCs undergo phenotypic switching from a quiescent contractile phenotype into other functionally distinct phenotypes. Although emerging evidence suggest that VSMC plasticity plays critical roles in the development of vascular diseases, little is known about the key determinant for controlling VSMC plasticity and fate. Methods and
-
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-27 Peter J Psaltis, Mau T Nguyen, Kuljit Singh, Ajay Sinhal, Dennis T L Wong, Richard Alcock, Sharmalar Rajendran, Rustem Dautov, Peter Barlis, Sanjay Patel, Thalia Salagaras, Jessica A Marathe, Christina A Bursill, Nicholas J Montarello, Stefan M Nidorf, Peter L Thompson, Julie Butters, Alana R Cuthbert, Lisa N Yelland, Juanita L Ottaway, Yu Kataoka, Giuseppe Di Giovanni, Stephen J Nicholls
Background Low-dose colchicine reduces the risk of cardiovascular events after myocardial infarction (MI). The purpose of this study was to assess the effect of colchicine post-MI on coronary plaque morphology in non-culprit segments by optical coherence tomography (OCT). Methods and Results COCOMO-ACS was a double-blind, placebo-controlled trial that randomized 64 patients (median age 61.5 years;
-
Burden of risk factors in women and men with unrecognised myocardial infarction: a systematic review and meta-analysis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-25 Julie A E van Oortmerssen, Noluthando Ntlapo, Martijn J Tilly, Wichor M Bramer, Hester M den Ruijter, Eric Boersma, Maryam Kavousi, Jeanine E Roeters van Lennep
Aims Unrecognised myocardial infarction (MI) is a MI that remains undetected in the acute phase and is associated with an unfavourable prognosis. With this systematic review and meta-analysis, we evaluated the burden of cardiovascular risk factors in individuals with unrecognised MI. Methods and Results We searched general population-based cohort studies diagnosing unrecognised MI by electrocardiogram
-
Physiological and pathological ventricular hypertrophy: a role for Cavin-2 mediated Akt regulation. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-24 Raffaele Coppini,Lucrezia Giammarino,Elisabetta Cerbai
-
Heart brain axis in health and disease: role of innate and adaptive immunity Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-24 Alba Simats, Hendrik Sager, Arthur Liesz
The importance of the brain-heart interaction has been increasingly recognized as a critical physiological axis that is altered in disease. In this review, we explore the intricate relationship between the central nervous system and cardiovascular health, focusing particularly on immunological mechanisms that influence the course of both neurological and cardiovascular diseases. While previous studies
-
The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-24 Marcella S Conning-Rowland, Marilena Giannoudi, Michael Drozd, Oliver I Brown, Nadira Y Yuldasheva, Chew W Cheng, Paul J Meakin, Sam Straw, John Gierula, Ramzi A Ajjan, Mark T Kearney, Eylem Levelt, Lee D Roberts, Kathryn J Griffin, Richard M Cubbon
Aims Diabetes mellitus (DM) increases heart failure incidence and worsens prognosis, but its molecular basis is poorly defined in humans. We aimed to define the diabetic myocardial transcriptome and validate hits in their circulating protein form to define disease mechanisms and biomarkers. Methods and Results RNA-sequencing data from the Genotype-Tissue Expression (GTEx) project was used to define
-
A reporter system for live cell tracking of human cardiomyocyte proliferation. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-23 Alessia Costa,Hannah Jill Hunkler,Shambhabi Chatterjee,Sarah Cushman,Erika Hilbold,Ke Xiao,Dongchao Lu,Julia Leonardy,Malte Juchem,Marida Sansonetti,Jeannine Hoepfner,Thomas Thum,Christian Bär
-
Single-cell analysis reveals the implication of vascular endothelial cell-intrinsic ANGPT2 in human intracranial aneurysm Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-22 Guo Yu, Jia Li, Hongfei Zhang, Huaxing Zi, Mingjian Liu, Qingzhu An, Tianming Qiu, Peiliang Li, Jianping Song, Peixi Liu, Kai Quan, Sichen Li, Yingjun Liu, Wei Zhu, Jiulin Du
Aims While previous single-cell RNA sequencing (scRNA-seq) studies have attempted to dissect intracranial aneurysm (IA), the primary molecular mechanism for IA pathogenesis remains unknown. Here, we uncovered the alterations of cellular compositions, especially the transcriptome changes of vascular endothelial cells (ECs), in human IA. Methods and results We performed scRNA-seq to compare the cell
-
Trajectories of cardiovascular ageing – from molecular mechanisms to clinical implementation Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-22 Stefano Ministrini, Florian A Wenzl, Thomas F Lüscher, Giovanni G Camici
Due to its peculiar structure and function, the cardiovascular system is particularly vulnerable to the detrimental effects of ageing. Current knowledge about the molecular mechanisms of ageing revealed the processes actively promoting ageing, e.g. progressive telomeres shortening, and the mechanisms opposing it, e.g. endogenous production of antioxidant substances. This knowledge can be used to measure
-
Anti-ageing interventions for the treatment of cardiovascular disease Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-22 Mahmoud Abdellatif, Sophie T Schmid, Alexander Fuerlinger, Guido Kroemer
As the global demographic landscape continues to shift towards an aged population, so does the medical and socioeconomic burden of cardiovascular diseases. Indeed, ageing is one of, if not the, key risk factor for the development of cardiovascular diseases. However, there are currently no approved cardiovascular therapeutics that primarily target the molecular and cellular mechanisms underlying the
-
Smooth muscle-specific deletion of Ccn2 causes severe aorta malformation and atherosclerosis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-22 Jannik H Larsen, Julie S Hegelund, Matilde K Pedersen, Cecilie M Andersson, Caroline A Lindegaard, Didde R Hansen, Jane Stubbe, Jes S Lindholt, Camilla S Hansen, Andrietta Grentzmann, Maria Bloksgaard, Boye L Jensen, Raúl R Rodriguez-Díez, Marta Ruiz-Ortega, Sebastian Albinsson, Gerard Pasterkamp, Michal Mokry, Andrew Leask, Roel Goldschmeding, Bartosz Pilecki, Grith L Sorensen, Charles Pyke, Martin
Aims Cellular Communication Network Factor 2 (CCN2) is a matricellular protein implicated in fibrotic diseases, with ongoing clinical trials evaluating anti-CCN2-based therapies. By uncovering CCN2 as abundantly expressed in non-diseased artery tissue, this study aimed to investigate the hypothesis that CCN2 plays a pivotal role in maintaining smooth muscle cell (SMC) phenotype and protection against
-
-
Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischemic cardiomyopathy Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-19 Xian-Liang Tang, Marcin Wysoczynski, Anna M Gumpert, Mitesh Solanki, Yan Li, Wen-Jian Wu, Shirong Zheng, Halina Ruble, Hong Li, Heather Stowers, Shengnan Zheng, Qinghui Ou, Nida Tanveer, Jan Slezak, Dinesh K Kalra, Roberto Bolli
Aims The development of cell therapy as a widely-available clinical option for ischemic cardiomyopathy is hindered by the invasive nature of current cell delivery methods. Furthermore, the rapid disappearance of cells after transplantation provides a cogent rationale for using repeated cell doses, which, however, has not been done thus far in clinical trials because it is not feasible with invasive
-
PITX2 deficiency leads to atrial mitochondrial dysfunction Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-12 Jasmeet S Reyat, Laura C Sommerfeld, Molly O’Reilly, Victor R Cardoso, Ellen Thiemann, Abdullah O Khan, Christopher O’Shea, Sönke Harder, Christian Müller, Jonathan Barlow, Rachel J Stapley, Winnie Chua, S Nashitha Kabir, Olivia Grech, Oliver Hummel, Norbert Hübner, Stefan Kääb, Lluis Mont, Stéphane N Hatem, Joris Winters, Stef Zeemering, Neil V Morgan, Julie Rayes, Katja Gehmlich, Monika Stoll, Theresa
Aim Reduced left atrial PITX2 is associated with atrial cardiomyopathy and atrial fibrillation. PITX2 is restricted to left atrial cardiomyocytes in the adult heart. The links between PITX2 deficiency, atrial cardiomyopathy and atrial fibrillation are not fully understood. Methods and Results To identify mechanisms linking PITX2 deficiency to atrial fibrillation, we generated and characterized PITX2-deficient
-
Sudden Unexpected Death in Epilepsy: Respiratory vs. Cardiac Contributions. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-07 Susan Lin,Theodore H Schwartz,Geoffrey S Pitt
Sudden Unexpected Death in Epilepsy (SUDEP) poses a significant risk to life expectancy for individuals with epilepsy. Mechanistic insight, while incomplete, has advanced through clinical observational studies and animal models. Yet we lack preventative therapies, which will depend on understanding SUDEP mechanisms. Recurrent convulsive seizures are the major SUDEP risk factor. Cardiorespiratory dysfunction
-
Nuclear factor of activated T-cells 5 is indispensable for a balanced adaptive transcriptional response of lung endothelial cells to hypoxia Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-07 Hebatullah Laban, Sophia Siegmund, Katharina Schlereth, Felix A Trogisch, Alia Ablieh, Lennart Brandenburg, Andreas Weigert, Carolina De La Torre, Carolin Mogler, Markus Hecker, Wolfgang M Kuebler, Thomas Korff
Aims Chronic hypoxia causes detrimental structural alterations in the lung, which may cause pulmonary hypertension and are partially mediated by the endothelium. While its relevance for the development of hypoxia-associated lung diseases is well known, determinants controlling the initial adaptation of the lung endothelium to hypoxia remain largely unexplored. Methods and results We revealed that hypoxia
-
Calciprotein particle counts associate with vascular remodelling in chronic kidney disease. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-05 Lian Feenstra,Melanie Reijrink,Andreas Pasch,Edward R Smith,Lotte M Visser,Marian Bulthuis,Monique E Lodewijk,Mirjam F Mastik,Marcel J W Greuter,Riemer H J A Slart,Douwe J Mulder,Robert A Pol,Charlotte A Te Velde-Keyzer,,Guido Krenning,Jan-Luuk Hillebrands
AIMS Calciprotein particles (CPPs) are circulating calcium and phosphate nanoparticles associated with development of vascular calcification (VC) in chronic kidney disease (CKD). Although recent studies have been focusing on associations of CPPs with presence of VC in CKD, insights in the underlying processes and mechanisms by which CPPs might aggravate VC and vascular dysfunction in vivo are currently
-
Slack K+ channels confer protection against myocardial ischemia/reperfusion injury Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-05 Anna Roslan, Katharina Paulus, Jiaqi Yang, Lucas Matt, Helmut Bischof, Natalie Längst, Sophia Schanz, Annika Luczak, Melanie Cruz Santos, Sandra Burgstaller, David Skrabak, Nadja I Bork, Roland Malli, Achim Schmidtko, Meinrad Gawaz, Viacheslav O Nikolaev, Peter Ruth, Rebekka Ehinger, Robert Lukowski
Aims Na+-activated Slack potassium (K+) channels are increasingly recognized as regulators of neuronal activity, yet little is known about their role in the cardiovascular system. Slack activity increases when intracellular Na+ concentration ([Na+]i) reaches pathophysiological levels. Elevated [Na+]i is a major determinant of the ischemia and reperfusion (I/R)-induced myocardial injury, thus we hypothesized
-
Neuroimmune circuits in the plaque and bone marrow regulate atherosclerosis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-08-01 Teresa Gerhardt, Pacific Huynh, Cameron S McAlpine
Atherosclerosis remains the leading cause of death globally. Although its focal pathology is atheroma that develops in arterial walls, atherosclerosis is a systemic disease involving contributions by many organs and tissues. It is now established that the immune system causally contributes to all phases of atherosclerosis. Recent and emerging evidence positions the nervous system as a key modulator
-
ORION-8: one step closer to understanding the safety and efficacy of inclisiran. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Lale Tokgözoğlu,Giuseppe Danilo Norata
-
Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Yu-Jen Wang,Christian M Matter
-
70 years of the Polish Cardiac Society. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Przemysław Mitkowski,Adam Witkowski,Piotr Szymański,Marek Gierlotka,Robert Gil
-
-
Biological basis and treatment of frailty and sarcopenia. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Ryosuke Sato,Mirela Vatic,Guilherme Wesley Peixoto da Fonseca,Stefan D Anker,Stephan von Haehling
In an ageing society, the importance of maintaining healthy life expectancy has been emphasized. As a result of age-related decline in functional reserve, frailty is a state of increased vulnerability and susceptibility to adverse health outcomes with a serious impact on healthy life expectancy. The decline in skeletal muscle mass and function, also known as sarcopenia, is key in the development of
-
Phosphodiesterase-mediated modulation of subcellular cAMP levels to reduce heart failure. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Maurizio Forte,Giacomo Frati,Sebastiano Sciarretta
-
Aquaporin in diabetes: more underwater enemies? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Virginie Montiel,Jean-Luc Balligand
-
Altered cardiac energetics in mice lacking Scn1b. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Jessa L Aldridge,Emily Davis Alexander,Allison A Franklin,Chad R Frasier
-
Imaging the cerebral vasculature at different scales: translational tools to investigate the neurovascular interfaces Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 L Carnevale, G Lembo
The improvements in imaging technology opened up the possibility to investigate the structure and function of cerebral vasculature and the neurovascular unit with unprecedented precision and gaining deep insights not only on the morphology of the vessels, but also regarding their function and regulation related to the cerebral activity. In this review we will dissect the different imaging capabilities
-
CircCHSY1 protects hearts against ischemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Jiliang Tan, Jie Min, Yun Jiang, Shenyan Liu, Minxia Ke, Zhinong Wang, Huang-Tian Yang
Aims Circular RNAs are important players involving in a variety of physiological and pathological processes. However, their functions and mechanisms during myocardial ischemic injury and protection remain largely unknown. We recently found significant alterations of many circRNAs including circCHSY1 following myocardial ischemia/reperfusion (I/R) injury, whereas their exact functions are unclear. Here
-
Zonation, ligand and dose dependence of S1PR1 signalling in blood and lymphatic vasculature Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-31 Ilaria Del Gaudio, Anja Nitzsche, Kevin Boyé, Philippe Bonnin, Mathilde Poulet, Toan Quoc Nguyen, Ludovic Couty, Hoa T T Ha, Dat T Nguyen, Amaury Cazenave-Gassiot, Khaoula Ben Alaya, Patrice Thérond, Jerold Chun, Markus R Wenk, Richard L Proia, Daniel Henrion, Long N Nguyen, Anne Eichmann, Eric Camerer
Aims Circulating levels of sphingosine 1-phosphate (S1P), an HDL-associated ligand for endothelial cell (EC) protective S1P receptor-1 (S1PR1), are reduced in disease states associated with endothelial dysfunction. Yet as S1PR1 has high affinity for S1P and can be activated by ligand-independent mechanisms and EC-autonomous S1P production, it is unclear if relative reductions in circulating S1P impact
-
Can β-blockers prevent intracranial aneurysm rupture? – insights from Computational Fluid Dynamics analysis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-30 Kornelia M Kliś, Roger M Krzyżewski, Borys M Kwinta, Krzysztof Stachura, Tadeusz J Popiela, Igor Szydłowski, Bartłomiej Łasocha, Tomasz Grodzicki, Jerzy Gąsowski
Aim Hypertension is a risk factor for intracranial aneurysm rupture. We analyzed whether the intake of drugs from specific classes of anti-hypertensive medications affects hemodynamic parameters of intracranial aneurysm dome. Methods and results We recorded medical history including medications and the in-hospital blood pressure values. We then obtained 3D reconstruction of each patients’ aneurysm
-
COVID-19 related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac MRI abnormalities Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-29 Andrej Ćorović, Xiaohui Zhao, Yuan Huang, Stephen Newland, Deepa Gopalan, James Harrison, Despina Giakomidi, Shanna Chen, Natalia S Yarkoni, Christopher Wall, Marta Peverelli, Rouchelle Sriranjan, Arianna Gallo, Martin J Graves, Andrew Sage, Paul A Lyons, Nyarie Sithole, Martin R Bennett, James H F Rudd, Ziad Mallat, Tian X Zhao, Meritxell Nus, Jason M Tarkin
Aims While acute cardiovascular complications of COVID-19 are well-described, less is known about longer-term cardiac sequelae. For many individuals with cardiac signs or symptoms arising after COVID-19 infection, the aetiology remains unclear. We examined immune profiles associated with magnetic resonance imaging (MRI) abnormalities in patients with unexplained cardiac injury after COVID-19. Methods
-
GWAS breakthroughs: mapping the journey from one locus to 393 significant CAD associations Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-26 Rédouane Aherrahrou, Tobias Reinberger, Satwat Hashmi, Jeanette Erdmann
Coronary artery disease (CAD) poses a substantial threat to global health, leading to significant morbidity and mortality worldwide. It has a significant genetic component that has been studied through genome-wide association studies (GWAS) over the past 17 years. These studies have made progress with larger sample sizes, diverse ancestral backgrounds, and the discovery of multiple genomic regions
-
Pericytes in the brain and heart: functional roles and response to ischemia and reperfusion Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-26 Turgay Dalkara, Leif Østergaard, Gerd Heusch, David Attwell
In the last 20 years there has been a revolution in our understanding of how blood flow is regulated in many tissues. Whereas it used to be thought that essentially all blood flow control occurred at the arteriole level, it is now recognised that control of capillary blood flow by contractile pericytes plays a key role both in regulating blood flow physiologically and in reducing it in clinically-relevant
-
Inhibition of endothelial to mesenchymal transition in a large animal preclinical arterio-venous fistula model leads to improved remodeling and reduced stenosis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-25 Yang Xu, Adam Korayem, Ana S Cruz-Solbes, Nirupama Chandel, Tomoki Sakata, Renata Mazurek, Spyros A Mavropoulos, Taro Kariya, Tadao Aikawa, Kelly P Yamada, Valentina D'Escamard, Bhargavi V'Gangula, Andrew H Baker, Lijiang Ma, Johan L M Björkegren, Valentin Fuster, Manfred Boehm, Kenneth M Fish, Rami Tadros, Kiyotake Ishikawa, Jason C Kovacic
Aims Vein grafts are used for many indications, including bypass graft surgery and arterio-venous fistula (AVF) formation. However, patency following vein grafting or AVF formation is suboptimal for various reasons, including thrombosis, neointimal hyperplasia and adverse remodeling. Recently, endothelial to mesenchymal transition (EndMT) was found to contribute to neointimal hyperplasia in mouse vein
-
Crucial role for sensory nerves and Na/H exchanger inhibition in dapagliflozin and empagliflozin-induced arterial relaxation Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-25 Elizabeth A Forrester, Miguel Benítez-Angeles, Kaitlyn E Redford, Tamara Rosenbaum, Geoffrey W Abbott, Vincenzo Barrese, Kim Dora, Anthony P Albert, Johs Dannesboe, Isabelle Salles-Crawley, Thomas A Jepps, Iain A Greenwood
Aims Sodium/glucose transporter 2 (SGLT2 or SLC5A2) inhibitors lower blood glucose and are also approved treatments for heart failure independent of raised glucose. Various studies have showed that SGLT2 inhibitors relax arteries but the underlying mechanisms are poorly understood and responses variable across arterial beds. We speculated that SGLT2 inhibitor-mediated arterial relaxation is dependent
-
Corrigendum to: Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-23
-
Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-22 Hauke Horstmann, Nathaly Anto Michel, Xia Sheng, Sophie Hansen, Alexandra Lindau, Katharina Pfeil, Marbely C Fernández, Timoteo Marchini, Holger Winkels, Lucia Sol Mitre, Tijani Abogunloko, Xiaowei Li, Timothy Bon-Nawul Mwinyella, Mark Colin Gissler, Heiko Bugger, Timo Heidt, Konrad Buscher, Ingo Hilgendorf, Peter Stachon, Sven Piepenburg, Nicolas Verheyen, Thomas Rathner, Teresa Gerhardt, Patrick
Background and Aims The distinct functions of immune cells in atherosclerosis have been mostly defined by preclinical mouse studies. Contrastingly, the immune cell composition of human atherosclerotic plaques and their contribution to disease progression is only poorly understood. It remains uncertain whether genetic animal models allow for valuable translational approaches. Methods and Results Single
-
The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-19 Edina Cenko,Marija Zdravkovic,Dimitris Tousoulis,Teresa Padro,
-
Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-19 Tafadzwa T J Kufazvinei, Jason Chai, Katherine A Boden, Keith M Channon, Robin P Choudhury
After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of adverse outcomes, compared to patients without. Diabetes confers a 1.5–2-fold increase in early mortality and, importantly, this discrepancy has been consistent over recent decades, despite advances in treatment and overall survival. Certain assumptions have emerged to explain this increased risk, such as differences
-
CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-18 Zhicheng Pan, Jialan Lv, Liding Zhao, Kaidi Xing, Runze Ye, Yuesheng Zhang, Siyuan Chen, Peng Yang, Hailong Yu, Yangkai Lin, Ruobing Li, Dongfei Wang, Juan Fang, Yang Dong, Jianpeng Sheng, Xiaolin Wang, Ge Shan, Shan Zhang, Hongqiang Cheng, Qingbo Xu, Xiaogang Guo
Aims Circular RNAs (circRNAs) are considered important regulators of biological processes, but their impact on atherosclerosis development, a key factor in coronary artery disease (CAD), has not been fully elucidated. We aimed to investigate their potential use in patients with CAD and the pathogenesis of atherosclerosis. Methods and Results Patients with stable angina (SA) or acute coronary syndrome
-
Extra-domain A containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibody Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-18 Isabell Singerer, Laura Tempel, Katja Gruen, Judith Heiß, Clara Gutte, Mattia Matasci, Andrea Schrepper, Reinhard Bauer, Alexander Berndt, Christian Jung, P Christian Schulze, Dario Neri, Marcus Franz
Aims Pulmonary vascular and right ventricular remodelling processes are important for development and progression of pulmonary hypertension (PH). The current study analyzed the functional role of the extra domain A containing fibronectin (ED-A+ Fn) for the development of PH by comparing ED-A+ Fn knockout (KO) and wild-type (WT) mice as well as the effects of an antibody-based therapeutical approach
-
Beneficial normalization of cardiac repolarization by carnitine in transgenic SQT1 rabbit models Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-16 Ilona Bodi, Lea Mettke, Konstantin Michaelides, Tibor Hornyik, Stefan Meier, Saranda Nimani, Stefanie Perez-Feliz, Ibrahim el-Battrawy, Heiko Bugger, Manfred Zehender, Michael Brunner, Jordi Heijman, Katja E Odening
Aims Short-QT-syndrome type 1 (SQT1) is a genetic channelopathy caused by gain-of-function variants in HERG underlying the rapid delayed-rectifier K+ current (IKr), leading to QT-shortening, ventricular arrhythmias, and sudden cardiac death. Data on efficient pharmaco-therapy for SQT1 are scarce. In patients with primary carnitine-deficiency, acquired-SQTS has been observed and rescued by carnitine-supplementation
-
Genetic deletion or pharmacologic inhibition of HDAC6 protects the heart against ischemia/reperfusion injury by limiting TNFα-induced mitochondrial injury in experimental diabetes Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-13 Shelley L Baumgardt, Juan Fang, Xuebin Fu, Yanan Liu, Zhengyuan Xia, Ming Zhao, Ling Chen, Rachana Mishra, Muthukumar Gunasekaran, Progyaparamita Saha, Joseph M Forbess, Zeljko J Bosnjak, Amadou KS Camara, Judy R Kersten, Edward B Thorp, Sunjay Kaushal, Zhi-Dong Ge
Aims The histone deacetylase 6 (HDAC6) inhibitor, tubastatin A, reduces myocardial ischemia/reperfusion injury (MIRI) in type 1 diabetic rats. It remains unclear whether HDAC6 regulates MIRI in type 2 diabetic animals. Diabetes augments activity of HDAC6 and generation of tumor necrosis factor α (TNFα) and impairs mitochondrial complex I (mCI). Here we examined how HDAC6 regulates TNFα production,
-
Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-09 Claude F Albritton,Antentor Hinton,Annet Kirabo
-
Corrigendum to: Lamin: Guardian against DNA damage by transcription stress. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-09
-
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention Cardiovasc. Res. (IF 10.2) Pub Date : 2024-07-06 Umidakhon Makhmudova, Elisabeth Steinhagen-Thiessen, Massimo Volpe, Ulf Landmesser
Nucleic acid-based therapies are being rapidly developed for prevention and management of cardiovascular diseases (CVD). Remarkable advancements have been achieved in the delivery, safety, and effectiveness of these therapeutics in the past decade. These therapies can also modulate therapeutic targets that cannot be sufficiently addressed using traditional drugs or antibodies. Among the nucleic acid-targeted